Amanda E. Jones

Structures of human PRC2 with its cofactors AEBP2 and JARID2

Inhibition of PRC2 Activity by a Gain-of-Function H3 Mutation Found in Pediatric Glioblastoma

dCas9 fusion to computer-designed PRC2 inhibitor reveals functional TATA box in distal promoter region

The molecular hallmarks of epigenetic control

The mitophagy activator urolithin A is safe and induces a molecular signature of improved mitochondrial and cellular health in humans

Deubiquitylating enzymes and drug discovery: emerging opportunities

Mechanisms Regulating PRC2 Recruitment and Enzymatic Activity

PRC2 is high maintenance

Chromatin Connections to Pluripotency and Cellular Reprogramming

Regulation of chromatin by histone modifications

The multidimensional mechanisms of long noncoding RNA function

TGFβ signalling in context

The emerging role of lncRNAs in cancer

Super-Enhancers in the Control of Cell Identity and Disease

Role of the Polycomb Repressive Complex 2 (PRC2) in Transcriptional Regulation and Cancer

Targeting apoptosis in cancer therapy

Promiscuous RNA binding by Polycomb repressive complex 2

Histone Methyltransferase EZH2 Is Transcriptionally Induced by Estradiol as Well as Estrogenic Endocrine Disruptors Bisphenol-A and Diethylstilbestrol

Targeting ferroptosis as a vulnerability in cancer

The Noncoding RNA Revolution—Trashing Old Rules to Forge New Ones

Reprogramming and development in nuclear transfer embryos and in interspecific systems

Transcriptional regulation and nuclear reprogramming: roles of nuclear actin and actin-binding proteins

Epigenetic factors influencing resistance to nuclear reprogramming

Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy

Putting p53 in Context

Master Transcription Factors and Mediator Establish Super-Enhancers at Key Cell Identity Genes

Astemizole Arrests the Proliferation of Cancer Cells by Disrupting the EZH2-EED Interaction of Polycomb Repressive Complex 2

Long Noncoding RNA and Cancer: A New Paradigm

Structure and function of histone methylation binding proteinsThis paper is one of a selection of papers published in this Special Issue, entitled CSBMCB’s 51st Annual Meeting – Epigenetics and Chromatin Dynamics, and has undergone the Journal’s usual peer review process.

Modulation of Chromatin by Noncoding RNA

Traditional Chinese medicine as a cancer treatment: Modern perspectives of ancient but advanced science

Epigenetic regulation of ferroptosis by H2B monoubiquitination and p53

Epigenetic regulation in pluripotent stem cells: a key to breaking the epigenetic barrier

EED and KDM6B Coordinate the First Mammalian Cell Lineage Commitment To Ensure Embryo Implantation

Structural basis of histone H3K27 trimethylation by an active polycomb repressive complex 2

p53 genes function to restrain mobile elements

Transposons, p53 and Genome Security

USP49 deubiquitinates histone H2B and regulates cotranscriptional pre-mRNA splicing

The histone H2A deubiquitinase Usp16 regulates embryonic stem cell gene expression and lineage commitment

PRC2 Complexes with JARID2, MTF2, and esPRC2p48 in ES Cells to Modulate ES Cell Pluripotency and Somatic Cell Reprograming

Binding of different histone marks differentially regulates the activity and specificity of polycomb repressive complex 2 (PRC2)